Article Text

other Versions

Synergizing health: combined gynecological and bariatric robotic surgery for endometrial cancer in obese women
Free
  1. Anna Myriam Perrone1,2,
  2. Francesco Mezzapesa1,2,
  3. Paolo Bernante2,3,
  4. Francesca Balsamo3,
  5. Silvia Garelli4 and
  6. Pierandrea De Iaco1,2
    1. 1Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola-Malpighi, Bologna, Italy
    2. 2Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy
    3. 3Division of Metabolic and Bariatric Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola-Malpighi, Bologna, Italy
    4. 4Endocrinology and Diabetes Prevention and Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola-Malpighi, Bologna, Italy
    1. Correspondence to Dr Francesco Mezzapesa, Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola-Malpighi, Bologna, Emilia-Romagna, Italy; francesco.mezzapesa{at}studio.unibo.it

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Endometrial cancer is the most common gynecological tumor, with approximately 10 200 new cases in 2022 in Italy.1 Its incidence is on the rise, possibly linked to undefined factors, with many attributing it to the increasing rates of obesity in high-income countries. This is not an unreasonable assumption, considering the correlation between obesity and the general risk of cancer, as well as the effects of unopposed hyperestrogenism due to inadequate progesterone production from adipose tissue.2

    Strong evidence from the literature underscores the health benefits of weight reduction. It is particularly noteworthy for women with pre-cancerous lesions and early-stage tumors who wish to conceive.3 Rapid and significant weight loss can be achieved through bariatric surgery, and the combination of minimally invasive robotic surgery with sleeve gastrectomy seems to be a promising option for severely obese women (body mass index (BMI) >35 kg/m2) (Figure 1). This choice is supported by the minimally invasive approach recommended for endometrial cancer and the surgeon’s comfort with the robotic technique in severely obese patients4 (Online Supplemental File 1).

    Supplemental material

    Figure 1

    (Left) Robotic Assisted Total Hysterectomy: dissection of the left round ligament and development of the vesico-uterine plica. (Right) Sleeve gastrectomy using a linear mechanical stapler.

    Our experience has shown a significant and swift weight reduction in patients treated with this combined approach, which is often difficult to attain with various diets. Notably, patients typically have a history of repeated and prolonged attempts at various diets with no success. The surgical procedures have been free of short- and long-term complications, and adding the bariatric component to laparoscopy has not increased transfusion requirements or the need for intensive care. The average length of stay in hospital was about the same for patients with and without bariatric surgery, with similar times for dietary refeeding, recovery of other bodily functions such as bowel and urinary function, drain removal, and pain management.

    However, it is essential to underline the patients' limited compliance with accepting the combined procedure, with only 3 out of 13 patients potentially eligible for bariatric surgery. The reasons were not investigated with specific tools, but the consistent responses included the illusion that yet another diet could change their weight without resorting to bariatric surgery, and a lack of full awareness of their overweight status and its implications for their overall health.

    Video 1 Synergizing health: combined gynecological and bariatric robotic surgery for endometrial cancer in obese women.

    Data availability statement

    All data relevant to the study are included in the article or uploaded as supplementary information.

    Ethics statements

    Patient consent for publication

    References

    Supplementary materials

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Footnotes

    • Contributors All authors provided substantial contributions to the final video and had the opportunity to review and approve the planned submission. AMP, FM, PDI: methodology, data curation, writing, visualization, project administration. PB, FB, SG: methodology, data curation, review and editing. AMP: guarantor. AMP, PDI: conceptualization. AMP, FM, PB, FB, SG, PDI: writing – review and editing.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.